Supply Chain Council of European Union | Scceu.org
News

Tracking drugs in the supply chain still hampered by poor paperwork

As Americans debate whether to import prescription drugs from Canada to relieve rising costs, a new government report finds that 16% of medicines examined could not be traced back to their manufacturers, underscoring ongoing concerns about the security of the pharmaceutical supply chain.

Specifically, documentation was lacking or mismatched for six of 44 so-called high-risk prescription drugs, although in one instance, a wholesaler refused to provide paperwork, according to the report from the Office of Inspector General of the Department of Health and Human Services, which reviewed Medicare Part D claims that were billed between January and May 2018.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

Related posts

Hurricane Ian could have impact on supply chain issues

scceu

Unhappy Holidays ahead as Coupa study finds supply chain crisis leaves retailers pessimistic

scceu

Supply chain braces for next industrial revolution – Lloyd’s List

scceu